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Abstract
Background: Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) are bioactive lipid signaling molecules
implicated in tumor dissemination. Membrane-type matrix metalloproteinase 1 (MT1-MMP) is a membrane-tethered
collagenase thought to be involved in tumor invasion via extracellular matrix degradation. In this study, we investigated
the molecular requirements for LPA- and S1P-regulated tumor cell migration in two dimensions (2D) and invasion of
three-dimensional (3D) collagen matrices and, in particular, evaluated the role of MT1-MMP in this process.
Results: LPA stimulated while S1P inhibited migration of most tumor lines in Boyden chamber assays. Conversely,
HT1080 fibrosarcoma cells migrated in response to both lipids. HT1080 cells also markedly invaded 3D collagen matrices
(~700 μm over 48 hours) in response to either lipid. siRNA targeting of LPA1 and Rac1, or S1P1, Rac1, and Cdc42
specifically inhibited LPA- or S1P-induced HT1080 invasion, respectively. Analysis of LPA-induced HT1080 motility on
2D substrates vs. 3D matrices revealed that synthetic MMP inhibitors markedly reduced the distance (~125 μm vs. ~45
μm) and velocity of invasion (~0.09 μm/min vs. ~0.03 μm/min) only when cells navigated 3D matrices signifying a role for
MMPs exclusively in invasion. Additionally, tissue inhibitors of metalloproteinases (TIMPs)-2, -3, and -4, but not TIMP-1,
blocked lipid agonist-induced invasion indicating a role for membrane-type (MT)-MMPs. Furthermore, MT1-MMP
expression in several tumor lines directly correlated with LPA-induced invasion. HEK293s, which neither express MT1-
MMP nor invade in the presence of LPA, were transfected with MT1-MMP cDNA, and subsequently invaded in response
to LPA. When HT1080 cells were seeded on top of or within collagen matrices, siRNA targeting of MT1-MMP, but not
other MMPs, inhibited lipid agonist-induced invasion establishing a requisite role for MT1-MMP in this process.
Conclusion: LPA is a fundamental regulator of MT1-MMP-dependent tumor cell invasion of 3D collagen matrices. In
contrast, S1P appears to act as an inhibitory stimulus in most cases, while stimulating only select tumor lines. MT1-MMP
is required only when tumor cells navigate 3D barriers and not when cells migrate on 2D substrata. We demonstrate
that tumor cells require coordinate regulation of LPA/S1P receptors and Rho GTPases to migrate, and additionally,
require MT1-MMP in order to invade collagen matrices during neoplastic progression.
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Tumor cell invasion is a complex process involving
genetic and cellular alterations which lead to proteolysis
and dispersion through three-dimensional biological bar-
riers [1-4]. Type I collagen is the most abundant compo-
nent of the extracellular matrix (ECM), and is therefore a
significant obstacle for tumor cell dissemination into the
lymphatics, vasculature, and surrounding areas [5,6].
Thus, in most cases, collagen must be degraded in order
for tumor cells to spread into surrounding anatomic struc-
tures and metastasize [7]. Cell migration, governed by
polarity and reorganization of the cellular cytoskeleton, is
also an integral aspect of tumor cell invasion [8,9]. Dis-
secting the molecular requirements of tumor cell migra-
tion and invasion is necessary because the latter, in
conjunction with metastasis, is a significant cause of mor-
bidity and mortality in cancer patients [10].
Recent reports have identified two lipid signaling mole-
cules, lysophosphatidic acid (LPA) and sphingosine 1-
phosphate (S1P), in many critical biological events such
as development, angiogenesis, inflammation, and wound
repair [11-15]. LPA and S1P function as extracellular lipid
agonists which activate a subfamily of G protein-coupled
receptors (GPCRs) and subsequent downstream effectors
such as the small GTPases RhoA, Rac1, and Cdc42 [16-
20]. In addition to fundamental cellular signaling, LPA,
particularly in ovarian cancer, and S1P have been impli-
cated in tumor cell proliferation, anti-apoptosis, cytoskel-
etal rearrangement and migration, and invasion [21-26].
LPA1–3 receptors are thought to be involved in cell motility
and are aberrantly expressed in cancer cells [25,27]. S1P1–
3 are also involved in the regulation of cell migration and
play important roles in the vascular system [11,15].
Additional reports have linked LPA and S1P to the matrix
metalloproteinases (MMPs) [24,28,29]. The role of MMPs
in tumor invasion has been well documented [30-33] and
clinical cancer therapeutic trials have sought to target
these molecules albeit with disappointing results [34,35].
Membrane-type matrix metalloproteinase 1 (MT1-MMP),
also known as MMP-14, is a membrane-bound colla-
genase that has been shown to localize to the leading edge
of invading cells, degrade surrounding extracellular
matrix, and play a pivotal role in cancer cell dissemination
[36-39]. The objective of the current study, therefore, is to
further characterize the roles of LPA, S1P, and MMPs (spe-
cifically MT1-MMP) in the processes of tumor cell migra-
tion and invasion using both 2D migration analysis and
3D type I collagen invasion assays.
Our data demonstrate that LPA stimulated and S1P inhib-
ited migration of most tumor lines tested. In contrast,
HT1080 fibrosarcoma cells migrated in response to both
lipids. Invasion of 3D collagen matrices of HT1080 cells,
but not migration in either Boyden chambers or on colla-
gen-coated plastic, was blocked in the presence of syn-
thetic MMP inhibitors, and TIMP-2, -3, or -4. This
indicates that lipid-induced invasion of 3D collagen
matrices is an MT-MMP-dependent event. Transfection of
HT1080 cells with siRNAs identified LPA1, S1P1, Rac1,
Cdc42, and MT1-MMP as key components of the invasion
response. Additional experiments revealed that SKOV3
and HEK293 cell lines, which express low levels of MT1-
MMP, do not invade LPA-containing 3D collagen matrices
despite a marked ability to undergo LPA-induced migra-
tion. When HEK293 were transfected with cDNA encod-
ing MT1-MMP, LPA-induced invasion of 3D collagen
matrices occurred. Our results demonstrate that lipid ago-
nist-induced tumor cell invasion requires MT1-MMP, and
its signaling occurs via LPA1, S1P1, Rac1, and Cdc42. We
propose that coordinated signaling events between LPA
and S1P receptors, their effectors, and MT1-MMP are
required during tumor cell invasion of 3D collagen matri-
ces, but MT1-MMP is not required for tumor motility on
2D collagen substrates.
Results
LPA stimulates while S1P either inhibits or stimulates 
migration of tumor cells
To study the effects of LPA and S1P on migration of tumor
cell lines, modified Boyden chambers were utilized. Cells
were allowed to migrate for 4 hours in the presence or
absence of LPA or S1P. LPA stimulated migration in all
tumor cell lines examined, while S1P blocked migration
in almost all lines (Fig. 1). These data identified LPA as the
most potent migratory stimulus for the tumor cell lines
evaluated compared to chemotactic growth factors such as
EGF, FGF-2, HB-EGF, IGF-1, and PDGF (data not shown).
Thus, in this study we focused on LPA as a stimulus for
tumor cell migration and invasion.
Four cell lines were selected for further study due to their
marked LPA-migration response namely A2058
melanoma, SKOV3 ovarian carcinoma, human embry-
onic kidney (HEK) 293, and HT1080 fibrosarcoma. We
have previously shown that S1P strongly influences inva-
sive behavior of human endothelial cells (another highly
invasive cell type) in 3D collagen matrices [28,40]. The
effects of S1P were therefore also evaluated in these cell
lines. LPA produced a strong migratory response for these
cell lines, and in all but one case (HT1080) S1P inhibited
migration. Interestingly, HT1080 cells exhibited a strong
migratory response in the presence of both LPA and S1P,
contrary to the trend of the other cell lines. This result is
particularly intriguing because HT1080 cells are among
the most invasive tumor cell lines in both in vivo and in
vitro settings [41,42], suggesting a role for S1P responsive-
ness in highly invasive tumor cells.Page 2 of 23
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lipid agonist migration profile in select cell lines
An in vitro A/2 96-well invasion assay was utilized to study
the effects of LPA and S1P on tumor cell invasion of
highly concentrated (3.75 mg/ml or 2.0 mg/ml) 3D type I
collagen gels. LPA or S1P were polymerized in collagen
gels at 1 μM, and the four selected cell lines were placed
on the surface of either 3.75 or 2.0 mg/ml collagen matri-
ces and allowed to invade for 48 hours. Cultures were
then fixed and stained for imaging and quantification as
shown in Fig. 2A and 2B. Invading cultures are presented
as cross-sections to allow visualization of the monolayer
(arrows) and the underlying collagen matrix containing
invading tumor cells. The HT1080 cell line invaded and
migrated dramatically in response to both LPA and S1P
(Fig. 1 and Fig. 2). Invasion of the A2058 cell line was
stimulated by LPA, but was inhibited by S1P, consistent
with the migration profile of this cell line (Fig. 1 and 2A).
SKOV3 and HEK293 cells markedly migrated in response
to LPA in migration assays (Fig. 1), but were unable to
invade 3D collagen matrices in response to these lipids
(Fig. 2B).
Time-lapse analysis of LPA and S1P-induced tumor 
invasion of collagen matrices
Additional experiments utilized a new method for time-
lapse analysis of tumor cell invasion. In this assay, colla-
gen gels were placed into thin walled square glass casings.
Tumor cells were then seeded onto the surface of the gel
and the casings were placed horizontally so that tumor
invasion could be imaged parallel to the surface of the gel
and monolayer. Invasion time course experiments
revealed that LPA or S1P significantly increased the rate of
invasion of HT1080 cells as compared to DMEM control
(Fig. 3A, B, and 3D and Table 1). When 3.75 mg/ml type
I collagen gels containing either LPA or S1P were used,
HT1080 cells invade ~700 μm in 48 hours at a rate of 14–
15 μm/hr (See additional file 1: LPA Invasion to view 24
hours of the time-lapse imaging). Notably, the addition of
a synthetic inhibitor of MMPs (GM6001) completely
blocked LPA-induced invasion of 3D collagen matrices
over this time period (Fig. 3C, D and Table 1; see addi-
tional file 2: LPA+GM6001 Invasion to view 24 hours of
the time-lapse imaging) establishing a requirement for
MMPs in this process (see later on).
LPA stimulates and S1P inhibits migration of most tumor cell linesFigure 1
LPA stimulates and S1P inhibits migration of most tumor cell lines. Tumor cell migration analysis was performed on 
8 μm polycarbonate gelatin-coated membranes and 20 μg/ml of fibronectin. LPA and/or S1P (1 μM) were added to the lower 
chambers and cells were allowed to migrate for 4 hours. Membranes were removed, stained, and migrating cells were quanti-
tated using Scion® software and Microsoft Excel®. Data are expressed as mean number of migrating cells × 103 (± S.D.) and 
represent the results of quadruplicate experiments.
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collagen matrices through S1P1, LPA1, Rac1, and Cdc42
LPA and S1P have been shown to bind and signal through
GPCRs [12,18,27]. Therefore, we elected to characterize
which receptors were involved in lipid-induced invasion.
Treatment of HT1080 cells with 100 ng/μl of pertussis
toxin (PTX) blocked invasion (Fig. 4A) suggesting a role
for GPCRs in this process, particularly those that signal
through Gαi [43,44]. To identify the receptors required for
invasion, siRNAs targeting LPA1–3 and S1P1–3 receptors
were used. Interestingly, when HT1080 cells were allowed
to invade in the presence of LPA, invasion was blocked
only by siRNAs targeting LPA1 (Fig. 4B and data not
shown). When HT1080 cells were allowed to invade in
the presence of S1P, invasion was blocked by siRNAs tar-
geting only S1P1 (Fig. 4B and data not shown). Efficiency
LPA and S1P regulate tumor cell invasion of 3D collagen matricesFigure 2
LPA and S1P regulate tumor cell invasion of 3D collagen matrices. (A) HT1080, A2058, SKOV3 or HEK293 cells 
were induced to invade 3D collagen gels (3.75 mg/ml or 2.0 mg/ml) under serum-free conditions in the presence or absence of 
LPA alone (1 μM), S1P alone (1 μM), or both LPA and S1P (1 μM each). After 48 hours, cultures were fixed, stained, and 
images were acquired to demonstrate the effects of LPA and S1P on tumor cell invasion. Arrowheads indicate the position of 
the tumor cell monolayer at the initiation of invasion. Magnification = 20×. Scale bar = 50 μm. Inset (panel A) = higher power 
magnification of invading HT1080 cell. (B) Quantitation of tumor invasion from panel A. Data are expressed as mean numbers 
of invading cells per HPF (20×) (± S.D.) from a minimum of 20 fields.
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Time-lapse analysis of HT1080 invasion: LPA and S1P induce ~700 μm of invasion of 3D collagen matricesF gure 3
Time-lapse analysis of HT1080 invasion: LPA and S1P induce ~700 μm of invasion of 3D collagen matrices. (A) 
HT1080 cells were seeded onto 3.75 mg/ml collagen gels in glass casings (see methods for details) and allowed to invade for 48 
hours in the presence of DMEM, LPA, S1P, LPA and S1P (1 μM each) or LPA (1 μM) + GM6001 (5 μM). Digital images of rep-
resentative fields were captured at ten minute intervals. Using Metamorph®, invasion distance measurements at each time 
point from triplicate wells were obtained (n = 15). Magnification = 10×. Scale bars = 200 μm. (B) Data from panel A were plot-
ted versus time and rates of invasion were calculated using linear regression (see Table 1). Data are expressed as mean inva-
sion distance (n = 3 wells, ± S.D.) for each time point from triplicate experiments.
D
M
E
M
0 hours 18 hours 32 hours 48 hours
L
P
A
A.
B.
L
P
A
+
G
M
60
01
0 hours 18 hours 32 hours 48 hours
C.
0 hours 32 hours 48 hours18 hours
600
400
200
In
va
si
o
n
 D
is
ta
n
ce
 (
ȝm
)
Time (hours)
0 6 12 18 24 30 36 42 48
DMEM
LPA
S1P
LPA+S1P
LPA+GM6001
D.800
Molecular Cancer 2006, 5:69 http://www.molecular-cancer.com/content/5/1/69and specificity of mRNA knockdown was confirmed by
Real-Time Quantitative PCR analysis (Fig. 4C). These data
suggest that LPA- and S1P-induced invasion signal
through different receptors and are thus dissociable proc-
esses. These data are consistent with the observed inhibi-
tion of invasion by PTX.
We then investigated which of the GPCR effectors were
involved in lipid-induced invasion in our system. RhoA,
Rac1, and Cdc42 have each been implicated in tumor
motility and invasion [45,46], are downstream effectors
of both LPA1 and S1P1 [47,48], and therefore were candi-
dates for targeting. We transfected HT1080 cells with siR-
NAs targeting either RhoA, Rac1, Cdc42, or control
siRNAs (Luciferase and Lamin A/C) and assessed invasion
in the presence of 1 μM LPA or S1P. siRNA targeting of
RhoA had no effect on invasion in the presence of either
lipid (Fig. 5A). siRNA targeting of Rac1 inhibited invasion
in the presence of either LPA or S1P. Interestingly, siRNA
targeting of Cdc42 only inhibited S1P-induced invasion
(Fig. 5A). Efficiency and specificity of siRNA transfection
was assessed by Western blotting (Fig. 5B). These data
indicate that Rac1 and Cdc42 are important GPCRs
involved in lipid-induced invasion in our system. Further-
more, Rac1 is involved in both LPA and S1P-induced inva-
sion of 3D collagen matrices, while Cdc42 appears to be
required only for S1P-induced invasion.
MMPs are required for lipid agonist-induced tumor cell 
motility in 3D collagen matrices but not on 2D collagen 
substrates
Previous reports have indicated that tumor cell motility in
3D matrices can occur in the absence of proteolysis
(MMPs) [3,49], and that in some cases, MMPs are neces-
sary for motility on 2D substrates [50,51]. Therefore using
additional assays, we investigated whether lipid agonist-
induced motility and/or invasion of 3D collagen matrices
required MMPs. In modified Boyden chambers, the addi-
tion of the synthetic MMP inhibitors GM6001, Tumor-
necrosis-factor-α protease inhibitor (TAPI)-0, and TAPI-1
had no effect on HT1080 migration (Fig. 6). To compare
2D vs. 3D motility, the lipid-induced motility of HT1080
cells stably expressing nuclear GFP (Nuc-GFP HT1080) in
2D or 3D was assessed (Fig. 7). Briefly, Nuc-GFP HT1080
cells were either seeded on top of plastic dishes coated
with 50 μg/ml of collagen (2D) or embedded and polym-
erized within a 3.75 mg/ml collagen gel (3D). Cells were
tracked using time-lapse fluorescence microscopy, and
data was analyzed using Metamorph®software.
Metamorph® generated tracings (lines) by tracking nuclear
movement of individual cells over 24 hours (see methods
and figure legends for additional details). In 2D, the same
distances (~300 μm) and velocities (~0.21 μm/min) of
migration were noted regardless of the treatment (DMEM
vs. LPA vs. S1P; One-way ANOVA: p = 0.767). The addi-
tion of GM6001 only slightly decreased (DMEM) or
increased (S1P) the distances (~277 μm and ~322 μm)
and velocities of migration (0.019 μm/min and 0.023
μm/min; One-way ANOVA: p < 0.01; Fig. 8 and Table 2;
see additional file 3 and 4: 2D LPA and 2D LPA+GM6001
to view the time-lapse imaging of LPA-induced 2D motil-
ity with and without GM6001, respectively). However,
when distances and velocities of cells embedded within a
3.75 mg/ml 3D collagen matrix were assessed, the lipid
treatment and the addition of GM6001 had marked
effects. In the presence of either LPA or S1P cells invaded
~50 μm further (~125 μm vs. ~75 μm – t-test p < 0.01 for
both) and reached a velocity ~70% greater (0.085 μm/
min vs. ~0.050 μm/min – t-test p < 0.01 for both; see
Table 2) compared to invasion with no lipid (DMEM). In
the presence of DMEM, LPA, or S1P with GM6001 added
to the culture media, the distance (~45 μm) and velocity
(0.030 μm/min) of the invading cells was markedly
decreased (t-test p < 0.01) compared to treatment with
DMEM or the lipid alone (Fig. 8; additional file 5 and 6:
3D LPA and 3D LPA+GM6001 to view the time-lapse
imaging of LPA-induced invasion of cells embedded in
Table 1: LPA and S1P accelerate MT1-MMP-mediated HT1080 invasion in 3D collagen matrices
Condition Rate of Invasion (μm/hr) R2
DMEM 4.930 0.8977
LPA 13.971 0.9986
S1P 15.672 0.9777
LPA + S1P 14.941 0.9916
LPA + GM6001 1.010 0.6971
Luciferase* 13.873 0.9997
Scrambled MT1-MMP* 13.532 0.9988
si MT1-MMP* 5.366 0.9584
HT1080 cells were allowed to invade for 48 hours in the presence or absence of the specified lipid. siRNA treated HT1080 cells (Luciferase, MT1-
MMP, or a control scrambled MT1-MMP) invaded in the presence of 1 μM LPA. Invasion distances were obtained with Metamorph® software by 
measuring pixel distance at each time point (five measurements per time point of duplicate or triplicate experiments.) Rates of invasion were 
calculated using linear regression analysis. R2 values denote the predictive potential of distance given time where 1.0 equals an exact correlation (* 
denotes separate experiment).Page 6 of 23
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LPA1 and S1P1 regulate HT1080 invasion of 3D collagen matrices in response to LPA and S1P, respectivelyFigure 4
LPA1 and S1P1 regulate HT1080 invasion of 3D collagen matrices in response to LPA and S1P, respectively. (A) 
HT1080 cells were allowed to invade in the presence of either LPA or S1P (1 μM) in the presence (+) or absence (-) of 100 ng/
μl of pertussis toxin (PTX). Cells were fixed, stained, and quantitated as described in Fig. 2. (B) HT1080 cells were transfected 
with siRNAs targeting the indicated genes and allowed to invade in the presence of either LPA or S1P (1 μM). Data are 
reported as mean numbers of invading cells per HPF (20×) (± S.D.) from a minimum of 20 fields. Statistical significance of 
means was determined using t-test where * = p < 0.01 relative to Luciferase (Luc) control for each lipid. (C) Real-time Quanti-
tative PCR (RTQ-PCR) values for LPA1 and S1P1 mRNA normalized against 18S RNA were used to illustrate selective targeting 
of the designated siRNA.
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Molecular Cancer 2006, 5:69 http://www.molecular-cancer.com/content/5/1/693D with and without GM6001, respectively). Together,
these data demonstrate that lipid-induced invasion of 3D
collagen matrices is a distinct process from lipid-induced
migration through chemotactic chambers or on 2D sub-
strata. In our assays, lipid-induced tumor cell invasion of
3D collagen barriers requires MMPs, whereas migration in
2D does not. Furthermore, these data demonstrate the
marked ability of lipid agonists to induce tumor cell inva-
sion of 3D collagen matrices, and that this invasion
requires MMP activity.
MT1-MMP is a key proteinase required for lipid-induced 
tumor cell invasion of 3D collagen matrices
Invasion of HT1080s in A/2 invasion assays in the pres-
ence of either LPA or S1P was abolished by adding 5 μM
of either GM6001, TAPI-0, or TAPI-1 to the culture media
(Fig. 9A, B and data not shown). Likewise, adding 5 μM of
either GM6001, TAPI-0, or TAPI-1 to the culture media
blocked LPA-induced A2058 melanoma invasion (data
not shown) further corroborating that lipid-induced
tumor cell invasion is an MMP-dependent event. How-
ever, synthetic inhibitors of MMPs such as GM6001 lack
specificity and inhibit a broad range of metalloprotein-
ases. To identify the predominant class of MMPs involved
in lipid-induced invasion of HT1080 cells, recombinant
Rac1 and Cdc42 are downstream effectors involved in LPA- and S1P-induced HT1080 invasion of 3D collagen matricesFigure 5
Rac1 and Cdc42 are downstream effectors involved in LPA- and S1P-induced HT1080 invasion of 3D collagen 
matrices. (A) HT1080 cells were transfected with siRNAs targeting the genes indicated and allowed to invade in the presence 
either LPA or S1P (1 μM). Data are expressed as mean numbers of invading cells per HPF (20×) (± S.D.) from a minimum of 20 
fields. Statistical significance of means was determined using t-test where * = p < 0.01 relative to Luciferase (Luc) control for 
each lipid. LMNA = Lamin A/C. (B) siRNA transfected HT1080 cell lysates were prepared for Western blot analysis. Lysates 
were probed for Lamin A/C, RhoA, Rac1, and Cdc42 to demonstrate siRNA specificity and probed for Actin as a loading con-
trol.
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Molecular Cancer 2006, 5:69 http://www.molecular-cancer.com/content/5/1/69TIMP-1, -2, -3, or -4 were added to A/2 invasion assays at
5 μg/ml (Fig. 9A) TIMPs exhibit specificity for differing
classes of metalloproteinases [soluble MMPs versus mem-
brane-type MMPs and the ADAM (adisintegrin and metal-
loproteinase)] family of metalloproteinases [52,53].
Therefore, we used this property of the TIMPs to identify
the particular class(es) of proteinase(s) involved in lipid-
induced invasion of HT1080 cells. TIMP-2, -3, and -4,
which are molecules known to inhibit both soluble,
ADAMs, and membrane-type MMPs, each blocked lipid-
induced invasion of HT1080 cells (Fig. 9A, B). The addi-
tion of TIMP-1, a TIMP capable of inhibiting soluble but
not membrane-type MMPs, had no effect on lipid-
induced HT1080 invasion. Analogous findings with
TIMPs were seen in time course experiments using the
side-view invasion system (See additional file 7:
LPA+TIMP-1 to view the time-lapse imaging of LPA-
induced HT1080 invasion in the presence of TIMP-1 and
additional file 8: LPA+TIMP-3 to view the time-lapse
imaging of LPA-induced HT1080 invasion in the presence
of TIMP-3). These results indicate a requirement for mem-
brane-bound MMPs in lipid-induced HT1080 invasion of
3D collagen matrices.
We next evaluated the intriguing observation that
although SKOV3 and HEK293 cells markedly migrated in
response to LPA in Boyden chamber assays, these cell lines
were unable to invade 3D collagen matrices in response to
these lipids as noted previously (Fig. 1 and Fig. 2B). West-
ern blot analysis was performed to characterize endog-
enous MT1-MMP levels of the four tumor cell types (Fig.
10A). Remarkably, the level of MT1-MMP expression
directly correlated with the ability of the tumor cell lines
to invade 3D collagen matrices.
To investigate further the role of MT1-MMP in LPA-
induced invasion, HEK293 cells (which do not invade in
response to LPA) were transfected with MT1-MMP cDNA
and allowed to invade in response to LPA for 48 hours.
Once transfected, HEK293 cells invaded in the presence of
LPA (Fig. 10B). Transfection with a control plasmid
(pAdTrack-CMV), or plasmids encoding human MT2-
MMP or MT3-MMP did not induce invasion despite
appropriate expression of the various proteins (Fig. 10C).
These data illustrate that MT1-MMP is required for LPA-
induced invasion of HEK293 cells. The HEK293 cells also
represent an interesting new model to assess tumor cell
invasion due to their inability to invade unless genes such
as MT1-MMP are supplied by transfection.
Next, we evaluated the role of MT1-MMP in lipid-induced
invasion of HT1080 cells using the A/2 invasion assay.
HT1080 cells were transfected with siRNAs targeting
either the membrane-type MT1-, MT2-, or MT3-MMPs,
soluble MMP-2 or MMP-9, or control siRNAs (scrambled
MT1-MMP, Lamin A/C, or Luciferase GL2 duplex) prior to
initiation of invasion assays. Transfection with either cus-
tom or SMARTpool® siRNAs targeting MT1-MMP were
capable of inhibiting MT1-MMP protein expression on
Western blot (Fig. 11A), pro-MMP-2 activation on gelatin
zymography (Fig. 11B), and tumor cell invasion of 3D
collagen matrices in response to either LPA or S1P (Fig.
12A, B). Transfection of HT1080 cells with siRNAs target-
ing the soluble MMPs (MMP-2 or MMP-9) or control siR-
NAs (Lamin A/C or Luciferase) had no influence on
HT1080 cell motility using modified Boyden chambers does not require MMPsFigure 6
HT1080 cell motility using modified Boyden chambers does not require MMPs. HT1080 cells were seeded onto 
porous (8 μm) polycarbonate membranes coated with type I collagen (1 mg/ml) and allowed to migrate for four hours in the 
presence of 1 μM LPA or S1P in the presence or absence of synthetic MMP inhibitors (5 μM GM6001, 5 μM TAPI-0, or 5 μM 
TAPI-1). Membranes were removed, stained, and migrating cells were quantitated using Scion® software and Microsoft Excel®. 
Data are expressed as mean number of migrating cells × 103 (± S.D.) and represent the results of quadruplicate experiments.
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Molecular Cancer 2006, 5:69 http://www.molecular-cancer.com/content/5/1/69invasion (Fig. 12A, B). Similarly, invasion time course
experiments revealed that HT1080 cells transfected with
MT1-MMP siRNA exhibited nearly a 3-fold slower rate of
invasion (~5 μm/hr vs. ~14 μm/hr for MT1-MMP and
Luciferase, respectively) and decreased distance of inva-
sion (~200 μm vs. ~700 μm) compared to Luciferase or
scrambled MT1-MMP controls (Fig. 13A–D and Table 1).
Collectively, our data identifies MT1-MMP as a key protei-
nase involved in lipid agonist-induced signaling and
tumor cell invasion of 3D collagen matrices.
MT1-MMP is required for lipid-induced invasion of tumor 
cells embedded within 3D collagen matrices
Cells embedded within 3D collagen matrices can exhibit
altered cellular behavior compared to cells cultured on the
surface of collagen matrices [5,54,55]. Therefore, the role
of MT1-MMP in lipid-induced invasion of HT1080 cells
embedded within 3.75 mg/ml 3D collagen was assessed
(as described in Figure 7). Nuc-GFP HT1080 cells were
transfected with siRNAs targeting MT1-MMP (custom) or
Luciferase (control) prior to initiation of the assays. Cell
Time-lapse assessment of lipid agonist-induced HT1080 cell motility on 2D collagen substrates versus 3D collagen matricesF gure 7
Time-lapse assessment of lipid agonist-induced HT1080 cell motility on 2D collagen substrates versus 3D colla-
gen matrices. Nuc-GFP HT1080 cells were seeded on 2D plastic dishes coated with 50 μg/ml of collagen or embedded 
within a 3.75 mg/ml type I collagen matrix and their motility was analyzed using Metamorph® software. Digital fluorescent 
images were acquired every 15 minutes and arranged in sequential order. A single cell is shown either moving on top of a dish 
(2D) or through 3.75 mg/ml collagen matrix (embedded in 3D) at 6 hour intervals for 24 hours. Tracings (generated by Meta-
morph®) of the continuous movement of these cells over the 24 hour time period are shown by the blue lines. (Note: Meta-
morph® creates a yellow line on a black background which is difficult to see. Therefore, the images were inverted to turn the 
yellow line blue and the black background white.) A blue (yellow) circle indicates the current position of the cell and a black 
(white) circle indicates the previous position. Subsequent tracings were converted to grayscale. Magnification = 20×. Scale bars 
= 50 μm.
HT1080 motility in 2D HT1080 motility in 3D
Time = 0 hrs
Time = 6 hrs
Time = 12 hrs
Time = 18 hrs
Time = 24 hrs
Time = 0 hrs
Time = 6 hrs
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Time = 18 hrs
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Molecular Cancer 2006, 5:69 http://www.molecular-cancer.com/content/5/1/69nuclei were tracked in 3D matrices as illustrated in Figure
7. Representative 24 hour tracings of nuclear movements
are presented (Fig. 14). Cells transfected with custom
MT1-MMP siRNA exhibited both decreased distance
(~138 μm vs. ~90 μm – t-test p < 0.01) and velocity
(~0.096 μm/min vs. ~0.064 μm/min – t-test p < 0.01) of
Lipid agonist-induced tumor cell motility requires MMPs in 3D collagen matrices but not on 2D collagen substratesFigure 8
Lipid agonist-induced tumor cell motility requires MMPs in 3D collagen matrices but not on 2D collagen sub-
strates. Five individual cell tracings generated by Metamorph® (grayscale) in the presence of the specified lipid with or without 
5 μM GM6001 (see Table 2 for distance and velocity calculations). Magnification = 20×. Scale bars = 100 μm.
2D Tracings 2D Tracings3D Tracings 3D Tracings
S1P
DMEM
LPA
(+) GM6001(–) GM6001
Table 2: The synthetic MMP inhibitor GM6001 decreases distance and reduces velocity of lipid-induced HT1080 motility in 3D collagen 
matrices but not on 2D collagen substrates.
Condition (over 24 
hours)
Avg. Distance μm (2D) Avg. Distance μm (3D) Avg. Velocity μm/min 
(2D)
Avg. Velocity μm/min 
(3D)
DMEM 303.68 ± 71.1 73.07 ± 31.74 0.21 ± 0.049 0.050 ± 0.022
DMEM + GM6001 277.38 ± 29.38 45.06 ± 15.17 0.19 ± 0.020 0.031 ± 0.010
LPA 298.58 ± 41.18 128.00 ± 56.98 0.21 ± 0.029 0.088 ± 0.039
LPA + GM6001 303.18 ± 55.41 40.43 ± 6.08 0.21 ± 0.038 0.028 ± 0.0042
S1P 303.05 ± 33.78 116.24 ± 25.39 0.21 ± 0.028 0.080 ± 0.017
S1P + GM6001 322.93 ± 69.05 44.598 ± 9.25 0.23 ± 0.049 0.031 ± 0.0057
Luciferase* N/A 138.43 ± 57.71 N/A 0.096 ± 0.040
si MT1-MMP* N/A 92.15 ± 35.90 N/A 0.064 ± 0.025
Nuc-GFP HT1080 cells were seeded on 2D plastic dishes coated with 50 μg/ml of collagen or embedded within a 3.75 mg/ml type I collagen matrix 
and their motility was analyzed using Metamorph® software (see Fig. 7) in the presence of the specified lipid with or without GM6001. siRNA 
(Luciferase or custom MT1-MMP) treated nuc-GFP HT1080 cells were only analyzed in 3D (see Fig. 14). Data are expressed as the average total 
distance (μm) or average velocity (μm/min) ± S.D. of 15 tracings per condition. [Note: 96 distances and velocities (144 for siRNA experiments) 
were generated per tracing for a total of 1440 (2160) data points]. Statistical significance of means was determined using either One-way ANOVA 
or t-test where p < 0.05 was deemed statistically signficant (see text for specific comparisons).Page 11 of 23
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Molecular Cancer 2006, 5:69 http://www.molecular-cancer.com/content/5/1/69invasion in 3D collagen matrices in the presence of LPA
(Fig. 14 and Table 2) similar to that observed when
HT1080 cells were treated with 5 μM GM6001 (Fig. 8 and
Table 2). Additional experiments using 1 μM S1P yielded
similar results (data not shown). These data indicate that
lipid-induced dissemination of individual tumor cells
embedded in 3D collagen matrices also requires MT1-
MMP.
Discussion
LPA and S1P are collaborative regulators of tumor cell 
migration and invasion
LPA receptors are classic GPCRs, and have been shown to
be abnormally expressed in cancer cells [25,27]. LPA is
also elevated in the plasma of patients with ovarian carci-
noma, indicating a link between LPA and early intraperi-
toneal dissemination [24,56]. Our data strongly indicate
that LPA is a potent tumor cell motility factor when com-
pared to other factors such as cytokines or chemokines.
The recent discovery of autotaxin, an enzyme that gener-
ates LPA or S1P and is expressed by tumor cells, highlights
the importance of LPA and S1P in tumor cell motility
[22,57,58]. Intriguingly, our data suggest that LPA and
S1P exert opposing effects on most tumor cell types (Fig.
1). Previous studies establish that lipid agonist signaling
pathways may be particularly important in this context
[21,27,59-62]. By identifying differential receptors
involved in LPA and S1P signaling (i.e. LPA1 and S1P1)
and the various downstream GTPase effectors (e.g. Rac1
and Cdc42), we hypothesize that motility and invasion
are regulated by a balance between these pro- and anti-
migratory signals. Contrary to other tumor cell lines,
HT1080 cells are not inhibited by S1P; in fact, S1P actu-
ally stimulates HT1080 migration and invasion (Figs. 1
and 2). This cell line is also one of the most invasive
tumor types known [41,42,63]. Thus, the loss of S1P inhi-
bition, or the ability of S1P to stimulate a tumor cell, may
directly contribute to metastatic potential. Studies investi-
gating the molecular differences in lipid signaling and
their relevance to tumor cell invasion and metastasis in
vivo are underway [64] and should be the subject of future
work.
MT-MMPs are required for tumor cells to invade 3D collagen matricesFigure 9
MT-MMPs are required for tumor cells to invade 3D collagen matrices. (A) HT1080 cells were induced to invade 3D 
collagen gels (3.75 mg/ml) as in Fig. 2 in the presence of 1 μM LPA and the synthetic MMP inhibitor GM6001 (5 μM), or TIMP-
1, -2, -3, or -4 (5 μg/ml). Arrowheads indicate the position of the tumor cell monolayer at the initiation of invasion. Magnifica-
tion = 20×. Scale bar = 50 μm. (B) Quantitation of HT1080 invasion from panel A. Data are expressed as mean numbers of 
invading cells per HPF (20×) (± S.D.) from a minimum of 20 fields.
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HEK293 cells transfected with MT1-MMP cDNA invade 3D collagen gels in response to LPAFigure 10
HEK293 cells transfected with MT1-MMP cDNA invade 3D collagen gels in response to LPA. (A) Tumor cell 
lysates were prepared for Western blot analysis. Lysates were probed for MT1-MMP to assess protein expression in the four 
tumor cell lines. Lysates were probed for Actin as a loading control. (B) HEK293 cells were transfected with the pAdTrack-
CMV plasmid as a control, or plasmids encoding MT1-MMP, MT2-MMP, or MT3-MMP cDNA 24 hours prior to placement in 
invasion assays. Cells were allowed to invade 2.0 mg/ml collagen gels in the presence or absence of 1 μM LPA. Data are 
expressed as mean numbers of invading cells per HPF (20×) (± S.D.) from a minimum of 20 fields. (C) Lysates from HEK293 
cells transfected with cDNAs encoding the designated genes were prepared for Western blot analysis and probed for GFP, 
MT1-MMP, MT2-MMP, MT3-MMP, or Actin as a loading control. TRK = pAdTrack-CMV, MT1 = MT1-MMP, MT2 = MT2-MMP, 
MT3 = MT3-MMP.
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Molecular Cancer 2006, 5:69 http://www.molecular-cancer.com/content/5/1/69LPA and S1P regulate tumor cell invasion of 3D collagen 
matrices via MT1-MMP
When invasion of tumor cells was assessed, we found that
an ability to migrate in response to LPA did not necessar-
ily confer an invasive phenotype in 3D collagen matrices.
In fact, only a small subset of tumor cell lines screened in
our models show strong invasive behavior (i.e. HT1080
cells). By far the majority of cell lines do not substantially
invade in 3D collagen matrices under the conditions
described in this report (Fisher and Davis, unpublished
observations). One possible explanation for this result is
that Western blot analysis revealed that non-invasive cell
types (HEK293 or SKOV3) expressed low levels of MT1-
MMP, a proteinase known to be involved in tumor cell
invasion (Fig. 10A) [5,6,37]. When HEK293 cells were
transfected with cDNA encoding MT1-MMP, cells were
able to invade collagen matrices containing LPA (Fig. 9B).
Using HT1080 cells, we were able to again distinguish
MT1-MMP as a critical molecule involved in lipid-induced
invasion using siRNA transfection targeting this protein-
ase (Figs. 12, 13, 14) or the addition of chemical or pro-
tein inhibitors of this proteinase (Fig. 9). A critical
question that remains unanswered is the mechanism by
which LPA stimulates MT1-MMP-dependent invasion of
collagen matrices. One possibility is that LPA is involved
in localizing or stabilizing MT1-MMP to critical areas of
the cell surface required for matrix proteolysis during 3D
locomotion.
The work presented here shows that LPA can both stimu-
late tumor cell motility on 2D substrates (Figs. 1, 6, and
8) and tumor cell invasion of 3D collagen matrices (Figs.
2, 8, 10, and 12). Importantly, only the latter process
depends on the MT1-MMP proteinase (Figs. 6, 8, 10, 14,
and Table 2). Blockade of MT1-MMP using siRNA sup-
pression or proteinase inhibitors strongly suppressed
HT1080 movement in 3D collagen matrices and not on
2D collagen substrates. Also, HT1080 random cell motil-
ity on 2D substrates was not affected by LPA, while LPA
clearly stimulated tumor cell movement/invasion in 3D
collagen matrices. This data demonstrates that LPA
strongly stimulates MT1-MMP-dependent tumor cell
invasion behavior, and thus, is a critical co-factor along
with matrix proteolysis in tumor cell invasion. An impor-
tant unanswered question remains: how does LPA or S1P
affect the ability of MT1-MMP to coordinate these inva-
sive events? This central issue is fundamental to our
understanding of how tumor and other cells such as
endothelial cells invade 3D matrix environments. We
hypothesize that LPA facilitates the localization of MT1-
MMP to specialized areas of the cell membrane that are
necessary to drive tumor cell locomotion through 3D
siRNAs targeting MT1-MMP reduce protein levels and MMP-2 activity on gelatin zymographyFigure 11
siRNAs targeting MT1-MMP reduce protein levels and MMP-2 activity on gelatin zymography. (A) Invading 
HT1080 cells lysates were prepared for Western blot analysis and probed for MT1-MMP and Lamin A/C to demonstrate 
siRNA efficiency and specificity. Actin was used as a loading control. (B) Conditioned media from siRNA-treated HT1080 cells 
were collected after 48 hours of invasion and gelatin zymography was performed. Arrows denote pro-MMP-9, and pro- and 
active forms of MMP-2.
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MT1-MMP is required for lipid-induced invasion of HT1080 cells in 3D collagen gelsFigure 12
MT1-MMP is required for lipid-induced invasion of HT1080 cells in 3D collagen gels. (A) HT1080 cells were trans-
fected with control siRNAs (Luciferase, Lamin A/C, or a scrambled MT1-MMP), siRNAs targeting soluble MMP-2 or MMP-9, or 
siRNAs targeting MT1-MMP (MT1-C, MT1-SP). Cells were allowed to invade 3D collagen gels in response to LPA or S1P for 
48 hours prior to fixation and quantification of invasion as in Fig. 2. Data are expressed as mean numbers of invading cells per 
HPF (20×) (± S.D.) from a minimum of 20 fields per condition. Statistical significance of means was determined using t-test 
where * = p < 0.01 relative to Luciferase control. si = siRNA; Luc = Luciferase, LMNA = Lamin A/C, MT1-C = custom MT1-
MMP, MT1-SP = SMARTpool® MT1-MMP, MT1-sc = scrambled MT1-MMP. (B) siRNA transfected HT1080 cells from panel A 
were imaged as in Fig. 2 to demonstrate tumor cell invasion. Magnification = 20×. Scale bars = 50 μm. Arrowheads indicate the 
position of the monolayer at initiation of invasion.
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The rate of HT1080 invasion is dependent on MT1-MMPFigu e 13
The rate of HT1080 invasion is dependent on MT1-MMP. HT1080 cells transfected with siRNA targeting Luciferase 
(A), MT1-MMP (custom) (B), or scrambled MT1-MMP (C) were seeded onto 3.75 mg/ml collagen gels in glass casings (see 
methods for details) and allowed to invade for 48 hours in the presence 1 μM LPA. Data were collected as in Fig. 3 and were 
plotted versus time (D). Rates of invasion were calculated using linear regression (see Table 1). Data are expressed as mean 
rate of invasion (n = 3 wells, ± S.D.) for each time point from triplicate experiments. Magnification = 10×. Scale bars = 200 μm. 
Dashed line indicates front of tumor cell invasion. si = siRNA; Luc = Luciferase, MT1-C = custom MT1-MMP, MT1-sc = scram-
bled MT1-MMP.
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Molecular Cancer 2006, 5:69 http://www.molecular-cancer.com/content/5/1/69matrices. Other possibilities include that LPA stimulates
the co-association of MT1-MMP with critical co-regulatory
molecules such as collagen-binding integrins (e.g. α2β1,
α1β1, α10β1, α11β1). Preliminary experiments using siR-
NAs directed to MT1-MMP and the β1 integrin subunit
show that suppressing both of these genes at the same
time completely inhibits HT1080 invasion of 3D collagen
matrices (Fisher and Davis, unpublished observations).
Previous studies have implicated other MMPs (i.e. MMP-
2 and MMP-9) in tumor cell invasion and progression,
and that LPA triggers upregulation or activation of MMP-
2 [24,63,65-67]. However, in our system, siRNAs targeting
MMP-2 or -9 or other MT-MMPs did not influence tumor
invasion of collagen matrices (Fig. 12). Our data indicate
that MT1-MMP is the predominant proteinase involved in
lipid-induced invasion of collagen matrices. These conclu-
sions are similar to a recent study showing the selective
ability of MT-MMPs to stimulate tumor invasion with no
evidence presented for a role of soluble MMPs [5]. Addi-
tionally, MT1-MMP acts upstream and can activate MMP-
2. Thus, MT1-MMP appears to be the principle regulator
of LPA-induced invasion. However, markedly decreasing
levels of MT1-MMP via targeted siRNA transfection did
not completely block completely invasion in HT1080
cells as effectively as the addition of GM6001 (Figs. 3, 8,
and 12, 13, 14). In addition, the depth and numbers of
invading MT1-MMP-transfected HEK293 cells were not as
extensive as seen in HT1080 cells (Fig. 10). These results
may indicate a role for additional molecules (e.g. colla-
gen-binding integrins or multiprotein complexes involv-
ing MT1-MMP) in our invasion system. It is also plausible
that other cell surface expressed metalloproteinases (i.e.
other MT-MMPs or ADAMs) could contribute to degrada-
tion of matrix components and host/tumor interactions
(i.e. tumor-driven angiogenesis) not addressed here [63].
Additional studies are needed to identify and address the
role of key complementary molecules in tumor invasion
and how this relates to lipid-agonist induced invasion.
Conclusion
In this study, we demonstrated that LPA (and also S1P for
HT1080s) stimulated the processes of motility and inva-
sion through signaling of LPA1, S1P1, Rac1, Cdc42, and
MT1-MMP. In most tumor cell lines, LPA markedly stim-
ulated tumor cell motility while S1P functioned as an
inhibitor of migration (except for HT1080 cells). In 3D
collagen invasion assays, the invasion of HT1080 and
A2058 cell lines mimicked their migration profile.
HEK293 and SKOV3 cells did not invade 3D collagen
matrices, despite a marked ability to migrate in response
to LPA. The LPA1 and S1P1 GPCRs, along with Rac1 and
Cdc42 were identified as crucial components of lipid ago-
nist-induced invasion. Using our assays, we determined
MT1-MMP is required for tumor cell movement when cells are embedded within 3D collagen matricesFigure 14
MT1-MMP is required for tumor cell movement when cells are embedded within 3D collagen matrices. Repre-
sentative individual 24 hour tracings (illustrated in Fig. 7) of Luciferase or custom MT1-MMP siRNA transfected Nuc-GFP 
HT1080 cells embedded in 3D collagen matrices are presented (grayscale). Images were acquired every 10 minutes. Magnifica-
tion = 20×. Scale bars = 100 μm.
LPA
Luciferase si MT1-MMP
3D TracingsPage 17 of 23
(page number not for citation purposes)
Molecular Cancer 2006, 5:69 http://www.molecular-cancer.com/content/5/1/69that LPA-induced tumor cell invasion of 3D collagen
matrices required proteolysis distinguishing it from lipid-
induced migration through porous membranes or on 2D
substrata. MT1-MMP was identified as a key proteinase
involved in lipid agonist-induced invasion in our systems.
A schematic summarizing this data is presented in Figure
15. These results summarily address the importance of
LPA and S1P in tumor motility and invasion, and directly
link lipid agonist-induced tumor cell invasion of 3D col-
lagen matrices to proteolysis via MT1-MMP.
It is clear that tumor cell migration and invasion are mul-
tifaceted events that require a myriad of cellular processes
to act in concert to achieve cell movement and propulsion
through natural barriers. The systems described here illus-
trate innovative ways to study the molecules involved in
tumor locomotion. Using our systems, we identified
molecular components (e.g. LPA1, S1P1, Rac1, Cdc42, and
MT1-MMP) involved in lipid-induced HT1080 invasion
(Figs. 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14). We also quanti-
tated the effects of LPA, S1P, or reduced MT1-MMP pro-
tein expression on the distance and rate of HT1080
invasion using a new time-lapse analysis system (Figs. 3,
8, 13, 14, and Tables 1 and 2). We believe that these in
vitro 3D microassay collagen invasion systems represent
an important and attractive approach to study the molec-
ular requirements for tumor invasion and the mecha-
nisms underlying the ability of single tumor cells to
invade through 3D collagen matrices. Identifying the key
molecules involved in tumor migration and invasion will
provide better comprehension of these processes and ulti-
mately, may yield more specific cancer therapeutics, par-
ticularly those that target lipid agonist-induced migration
and MT1-MMP-mediated invasion.
Methods
Reagents
48-well micro-chemotaxis chambers and polycarbonate
membranes (8 μm pores) were purchased from Neuro
Probe, Inc. (Gaithersburg, MD). D-Erythro-sphingosine 1-
phosphate (S1P) and lysophosphatidic acid (LPA) 1-ole-
oyl-2-hydroxy-SN-glycero-3-phosphate, sodium salt were
purchased from Avanti Polar Lipids (Alabaster, AL). Rat
tail collagen type I was prepared at 7.1 mg/ml using the
method previously described [68]. Tumor cell lines were
purchased from American Type Culture Collection
(ATCC) (Manassas, VA). Dulbecco's Modified Eagle
Medium (DMEM), Lipofectamine 2000, and fetal bovine
serum (FBS) were from Invitrogen Life Technologies
(Rockville, MD). Bovine TIMP-1 and TIMP-2 were
obtained from Chemicon Corp (Temecula, CA). Recom-
binant TIMP-3 and TIMP-4 were from R&D Systems (Min-
neapolis, MN). A rabbit polyclonal antibody was
prepared against recombinant green fluorescent protein
(GFP) as described [69]. Human MT1-MMP (AF918, R&D
Systems, Minneapolis, MN), MT3-MMP (RP1-MMP-16,
Triple Point Biologics, Forest Grove, OR), and Rac1
(ARC01, Cytoskeleton, Denver, CO), and monoclonal
antibodies directed against human MT2-MMP (MAB916,
R&D Systems), Lamin A/C (MAB3211, Chemicon Corp),
Actin (JLA-20, Calbiochem, San Diego, CA), RhoA
(ARH01, Cytoskeleton), and Cdc42 (610929, BD Tans-
Schematic diagram summarizing the roles of LPA, S1P, RhoGTPases, and MT1-MMP in tumor migration and invasion of collagen matricesFigur  15
Schematic diagram summarizing the roles of LPA, S1P, RhoGTPases, and MT1-MMP in tumor migration and 
invasion of collagen matrices. LPA stimulates tumor cells migration while S1P inhibits migration of most tumor types on 
2D matrix substrates. Lipid-induced invasion of 3D collagen matrices, but not migration, requires MT1-MMP. Only tumor cell 
invasion of 3D matrices is blocked by MMP inhibitors.
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Molecular Cancer 2006, 5:69 http://www.molecular-cancer.com/content/5/1/69duction, San Jose, CA) were used for Western blot analysis
as described previously [70]. siGENOME SMARTpool®
reagents were products of Dharmacon (Lafayette, CO).
Plasmids encoding human MT1-MMP (EX-M0327-M02)
and MT3-MMP (EX-Q0300-M02) were obtained from
Genecopoeia (Germantown, MD). A plasmid encoding
human MT2-MMP (TC118648) was purchased from Ori-
gene (Rockville, MD). Other reagents were obtained from
Sigma (St. Louis, MO) unless noted.
Cell culture
Tumor cells were cultured in T-75 flasks and supplied with
DMEM supplemented with 10% FBS containing 100 μg/
ml gentamicin (Invitrogen), 100 μg/ml of streptomycin,
100 Units/ml of penicillin, and 0.25 μg/ml Amphotericin
B [Fungizone®, Invitrogen, Carlsbad, CA), and incubated
at 37°C with 5.0% CO2. The stable HT1080 cell line
expressing nuclear-GFP was cultured in media containing
10 μg/ml Blasticidin (Invitrogen). HEK293 cells were cul-
tured on flasks pre-coated with 20 μg/ml type I collagen in
PBS. Prior to use in experiments, cells were washed with
phosphate buffered saline (PBS), removed from monol-
ayer with trypsin-EDTA, neutralized with fetal bovine
serum, and centrifuged. Cells were then washed in two, 10
ml volumes of DMEM to remove residual serum.
Generation of stable HT1080s expressing nuclear-
localized GFP
A vector expressing nuclear-localized GFP (Nuc-GFP)
(vector pACGFP1-Nuc, 632431) was obtained from BD
Biosciences-Clontech (Mountain View, CA). The Nuc-GFP
insert was amplified via PCR using the following primers:
Nuc-GFP UP: 5'-CACCATGGTGAGCAAGGGCGCCGAG-
3' and Nuc-GFP DN: 5'-AGCAGTTATCTAGATCCGGT-
GGATC-3'. PCR product size was verified via agarose gel
electrophoresis, and following PCR purification (Qiagen,
Valencia, CA), was TOPO cloned into the pLenti6/V5-D-
TOPO lentiviral vector (Invitrogen). Following TOPO
cloning, One Shot Stbl3 Chemically Competent E. coli
were transformed with DNA. Individual clones contain-
ing the Nuc-GFP insert were verified via PCR and
sequence analysis. The 293FT lentiviral packaging cell line
was obtained from the ViraPower Lentiviral Gateway
Expression Kit (Invitrogen) and were cultured in 500 μg/
ml G418. Nuc-GFP lentivirus was produced following the
Invitrogen lentivirus protocol. HT1080s were infected
with Nuc-GFP lentivirus and were incubated for 72 hours
prior selection using 10 μg/ml of Blasticidin. HT1080s
were cultured in Blasticidin for 10 days to ensure stable
cell line selection, and Nuc-GFP expression was verified
via fluorescent microscopy.
96-well A/2 vertical collagen invasion assay
Three-dimensional (3D) collagen type I invasion assays
were adapted from previously described work [28].
Briefly, collagen gels (n = 3 gels per condition, 25 μl vol-
ume) were prepared as described [71] at a final concentra-
tion of 2.0 or 3.75 mg/ml and added to A/2 wells (4.5 mm
diameter) of 96-well plates (Costar, Corning, NY). 1 μM
S1P and/or LPA were incorporated into each gel prior to
polymerization and equilibration at 37°C and 5% CO2
for 45 minutes. After equilibration, 100 μl of media con-
taining a 1:250 dilution of RSII(+) (Transferrin, BSA, oleic
acid, and insulin) and 35,000 tumor cells were added to
each well. Cells were allowed to invade 3D collagen gels
for 48 hours. Culture media was removed and collagen
gels containing invading tumor cells were fixed in 3% glu-
taraldehyde in PBS for 30 minutes. Gels were stained with
0.1% toluidine blue in 30% methanol for 30 minutes
prior to destaining with water. Transected gels were
imaged using an inverted Nikon Eclipse TE2000-U micro-
scope, camera, and Metamorph® software (Molecular
Devices Corporation, Downington, PA) or were acquired
using an inverted Olympus microscope, camera, and
Kodachrome 64T color film. Kodachrome images were
scanned using a Polaroid SprintScan 4000 and PolaColor
Insight Software (Polaroid, Cambridge, MA). To quanti-
tate invasion of tumor cells in 3D collagen gels, cells were
counted with eyepiece equipped with an ocular grid. For
each condition, twenty random fields were selected and
the number of invading cells per high power field (HPF)
was counted manually at 20× magnification. Data are
reported as mean number of invading cells per HPF (±
S.D.).
Effects of metalloproteinase inhibitors and pertussis toxin 
on migration or invasion
GM6001 (Calbiochem) and TAPI-1 (Chemicon) were
reconstituted in DMSO at 2.5 mM. TAPI-0 (Chemicon)
was reconstituted in DMSO at 0.25 mM. TIMP-1, TIMP-2,
TIMP-3, and TIMP-4 were prepared at 100 μg/ml in 0.1%
BSA. To determine the effects of MMP inhibitors on tumor
cell migration and invasion, GM6001 (5 μM), TAPI-1 (5
μM), TAPI-0 (5 μM), and TIMPs 1–4 (5 μg/ml) were
added to upper chambers of migration assays and directly
to cell media in invasion assays. Likewise, 100 ng/μl of
pertussis toxin was added to cell media where noted.
Migration and invasion assays were performed as
described.
Transfection of HT1080 cells with siRNA
siGENOME SMARTpool® human MMP-2, MMP-9, MT1-
MMP, MT2-MMP, MT3-MMP, LPA1–3, S1P1–3, RhoA,
Rac1, and Cdc42 were purchased from Dharmacon. A 21-
nucleotide custom MT1-MMP siRNA described previously
by Weiss and colleagues [5] was prepared by Dharmacon.
A Lamin A/C siGENOME SMARTpool® siRNA and a Luci-
ferase GL2 duplex siRNA oligo (Dharmacon) were uti-
lized as controls. All siRNA transfections were performed
as described previously [72]; however, LipofectaminePage 19 of 23
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poses. Cells were allowed to recover from siRNA transfec-
tion for 18 hours prior to initiation of experiments. Cells
were allowed to invade for 48 hours as described above,
after which conditioned media were collected and stored
at -20°C. Invading tumor cells were extracted from colla-
gen matrices and stored at -20°C as described previously
[72]. The remaining wells were fixed, stained, quantitated,
and imaged as described.
Transfection of HEK293 cells with plasmids encoding 
human MT-MMPs
Plasmids encoding human MT1-, MT2-, and MT3-MMP
cDNA were purified using the Qiagen plasmid MIDI kit
(Valencia, CA). T-25 flasks were pre-coated with type I col-
lagen as described above, and HEK293 cells were cultured
to 80% confluency in 5 ml of culture media. On the day
of transfection, 6 μg of MT1, MT2, or MT3-MMP plasmid
DNA or the control vector pAdTrack-CMV encoding GFP
[73], kindly provided by Dr. Bert Vogelstein (Johns Hop-
kins University College of Medicine, Baltimore, MD), was
diluted into Opti-MEM I (Invitrogen) and mixed with
Lipofectamine 2000 to a final volume of 1 ml. The plas-
mid/Lipofectamine 2000/Opti-MEM solution was added
to the cells prior to overnight incubation. Cells were
washed, trypsinized, and seeded onto 2.0 mg/ml collagen
matrices as described above. Transfected HEK293 cells
were allowed to invade for 48 hours prior to fixation,
staining, and quantification as described above. For each
plasmid, protein expression was verified via Western blot
analysis.
Real-Time Quantitative PCR (RTQ-PCR)
LPA1 and S1P1 mRNA were quantified using the Applied
Biosystem apparatus 7500 Fast Real-Time PCR system.
Briefly, total RNA was extracted from siRNA-treated (Luci-
ferase, LPA1, and S1P1) HT1080 cells using the Totally
RNA Isolation kit (Ambion, Austin, TX) according to the
manufacturer's instructions. RNA (5 μg) was reversed
transcribed using StrataScript First Strand Synthesis Sys-
tem (Stratagene, Cedar Creek, TX). RTQ-PCR was per-
formed in a final volume of 20 μl containing 2 μl of a 1:5
dilution of each RNA template, 10 μl of a TaqMan® Fast
Universal PCR Master Mix, and 1 μl of a TaqMan® Gene
Expression Assays (Applied Biosystems, Foster City, CA).
Primers were designed using PrimerExpress sofware
(Applied Biosystems), and targeted sequences between
Exon 1 and Exon 2 (S1P1), between Exon 2 and Exon 3
(LPA1), and an inventoried eukaryotic 18S rRNA (internal
control). Each sample was assayed using three replicates
for each primer. The 18S rRNA-specific primer was used as
an internal standard. The cycling conditions were as fol-
lows: one cycle at 95°C for 20 seconds, followed by 40
cycles of PCR amplification, each consisting of 95°C for 3
seconds and 60°C for 30 seconds. ΔCt values were
obtained by subtracting the Ct value of the housekeeping
gene 18s rRNA from the Ct value for each indicated gene.
The ΔΔCt relative expression method was used to normal-
ize LPA1 and S1P1 to 18s rRNA as a housekeeping gene
(comparative Ct method). Data are reported as mean
expression values normalized to 18s RNA (± S.D.) of three
replicates per siRNA treatment.
Gelatin zymography and Western blotting
Gelatin zymography was performed with SDS-PAGE gels
containing 8.5% acrylamide and 1 mg/ml porcine gelatin.
Conditioned media from the HT1080 siRNA transfected
cells were prepared under non-reducing conditions. Gel
electrophoresis was performed at 150V for 55 minutes.
Zymograms were incubated for three 20 minute periods
in 100 mls of 2% Triton X-100 in water, washed twice in
distilled water, placed in 25 mM Tris-HCl (pH 7.5) con-
taining 5 mM CaCl2, and incubated overnight at room
temperature. The following morning, gels were stained
with 0.1% Amido Black in 30% methanol and 10% acetic
acid for 15 min and destained in 30% methanol and 10%
acetic acid for 1 hour at room temperature. Western blot
analysis was performed using 10% or 14% (for RhoA,
Rac1, and Cdc42) SDS-PAGE gels as described previously
[70] and probed with antibodies at the following concen-
trations: GFP, 0.1 μg/ml; MT1-MMP, 2 μg/ml; MT2-MMP,
1 μg/ml; MT3-MMP, 1 μg/ml; Lamin A/C, 2 μg/ml; Actin,
0.1 μg/ml; RhoA, 2 μg/ml; Rac1, 5 μg/ml; and Cdc42, 2
μg/ml
Time-lapse measurements and imaging of HT1080 
invasion
Hollow glass casings (3 × 3 × 8 mm) were designed by
Wale Apparatus (Hellertown, PA) to accommodate a col-
lagen gel and tumor cells during invasion. Collagen gels
were prepared at a final concentration of 3.75 mg/ml. 1
μM of S1P and/or LPA was incorporated into each gel
before filling each glass casing with ~20 μl of collagen.
Gels were allowed to polymerize and equilibrate at 37°C
with 5% CO2 for 45 minutes. After equilibration, 50 μl of
clear DMEM (Invitrogen) containing 25,000 HT1080 cells
was added to the upper portion of the glass casing above
the collagen. Cells were allowed to attach for 30 minutes
before the glass casings were secured in a horizontal plane
within the well of a 48 well plate (Costar) with sterile sil-
icon grease. Each well was then supplied with 500 μl of
media containing a 1:250 dilution RSII (+). Cells were
allowed to invade for 48 hours at 37°C with 5% CO2. Dig-
ital images were captured directly every ten minutes using
an inverted Nikon Eclipse TE2000-U microscope, camera,
and Metamorph® software (Molecular Devices Corpora-
tion, Downington, PA). Using Metamorph®, images of
individual fields of invading tumor cells were arranged in
sequential order. Distance of HT1080 invasion was meas-
ured using digital pixel measurements and plotted againstPage 20 of 23
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mined using linear regression statistical analysis. Data are
reported as the mean distance in micrometers of invading
cell fronts (± S.D.). Five measurements for each time point
of duplicate or triplicate experiments were performed.
Assessment of chemotactic migration
Modified Boyden chambers were utilized to assess lipid-
induced chemotactic directional migration. Polycar-
bonate filters (8 μm pores) were pre-coated with 1 mg/ml
type I collagen or gelatin in PBS. LPA and/or S1P in
DMEM containing a 1:250 dilution of reduced serum II
supplement [RSII(-)] (Transferrin, BSA, no oleic acid, and
insulin) were added to lower wells. Upper wells contained
a 1:250 dilution of RSII(-) and lower wells contained 20
μg/ml of fibronectin for gelatin-coated membranes. 5 ×
104 tumor cells were added to upper chambers and
allowed to migrate for 4 hours. Filters were removed and
stained with 0.1% amido black in 30% methanol and
10% acetic acid. Membrane-adherent migrating cells were
calculated using Scion® image and Microsoft® Excel. Migra-
tion data are represented mean number of migrating cells
× 103 (± S.D.) and represent the results of quadruplicate
experiments.
Tracking Nuclear-GFP HT1080 cells on collagen-coated 
plastic (2D) or embedded within in collagen matrices (3D)
To observe the movement of HT1080 cells embedded in
3D collagen matrices, nuc-GFP HT1080s or siRNA treated
(Luciferase or custom MT1-MMP) nuc-GFP HT1080s were
mixed 1:1 with non-fluorescent HT1080s. Cells were then
incorporated into a 3.75 mg/ml collagen matrix (n = 3 cul-
tures per condition) containing 1 μM LPA. 15 μl of colla-
gen and cell mixtures were added to square 384-well
tissue culture plates (VWR, West Chester, PA), and
allowed to equilibrate for 1 hour prior to addition of 60
μl of media containing a 1:250 dilution of RSII(+). 5 μM
GM6001 was added to the media as noted. Cells were
allowed to invade the surrounding matrix for 48 hours at
37°C with 5% CO2. Digital fluorescent images were cap-
tured directly with Metamorph® as described above. By
tracking fluorescent nuclei in chronological frames, Meta-
morph® generated cell tracings of the movements of indi-
vidual cells. For 2D tracings, nuclear-GFP HT1080 cells
were seeded on 6 well plates pre-coated (30 minutes) with
50 μg/ml of type I collagen and cultured with 2 mls of
media containing a 1:250 dilution of RSII (+). GM6001
was added as described. Images and cell tracings were gen-
erated by Metamorph® as described.
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